Much-needed doses are set to arrive Monday after the Food and Drug Administration authorized an emergency rollout of the vaccine developed by Moderna Inc. and the National Institutes of Health.
Red tape, staff shortages, testing delays and strong skepticism are keeping many patients and doctors from the drugs made by Eli Lilly and Co. and Regeneron Pharmaceuticals.
The Food and Drug Administration was evaluating a shot developed by Moderna Inc. and the National Institutes of Health and was expected to give it the green light soon, clearing the way for its use to begin as early as Monday.
As the coronavirus sidelines huge numbers of educators, school districts are turning to college students, who are learning online or home for extended winter breaks.
The suit alleges the governor’s executive order is unconstitutional and caused “unjust injury to [the restaurant’s] fundamental civil rights, liberty interests and property rights.”
Bearing down on a midnight shutdown deadline, top negotiators on a must-pass, almost $1 trillion COVID-19 economic relief package are committed to sealing an agreement Friday as they resolve remaining differences.
The latest case came Thursday as dozens of states filed an antitrust lawsuit against Google, alleging that the search giant exercises an illegal monopoly over the online search market, hurting consumers and advertisers.
The hack compromised federal agencies and “critical infrastructure” in a sophisticated attack that was hard to detect and will be difficult to undo, the Cybersecurity and Infrastructure Security Agency said in an unusual warning message.
Once FDA’s emergency use authorization is granted, Moderna will begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.
The pending bill is the first significant legislative response to the pandemic since the landmark CARES Act passed virtually unanimously in March, delivering $1.8 trillion in aid.
Nationally, the total number of people who are receiving traditional state unemployment benefits fell to 5.5 million from 5.8 million. That figure is down sharply from its peak of nearly 23 million in May.
The states are accusing the search giant of “anti-competitive conduct” in the online advertising industry, including a deal to manipulate sales with rival Facebook.
Allergies are always a question with a new medical product, but monitoring COVID-19 vaccines for any other, unexpected side effects is a bigger challenge than usual.
In a mixed and muted day of trading, the S&P 500 rose 6.55 points, or 0.2%, to 3,701.17. It’s within roughly 1 point of its record set last week.
U.S. officials say they’re actively negotiating for additional purchases of Pfizer’s coronavirus vaccine after passing up a chance to lock in a contract this summer since it was still unclear how well the shots would work.
The Federal Reserve said Wednesday that it will keep buying government bonds until the economy makes “substantial” progress—a step intended to reassure financial markets and keep long-term borrowing rates low indefinitely.
President-elect Joe Biden introduced Democratic primary rival Pete Buttigieg on Wednesday as his nominee for transportation secretary, calling the 38-year-old ex-mayor of South Bend “a new voice, with new ideas determined to move past old politics.”
Top congressional leaders are hoping to seal a deal as early as Wednesday that would extend aid to individuals and businesses and help ship coronavirus vaccines to millions.
Americans held back on spending during the start of the holiday shopping season, a troubling sign for retailers and the state of the U.S. economy.
The U.S. Supreme Court on Wednesday agreed to review a court decision that the NCAA has said blurred “the line between student-athletes and professionals” by removing caps on education-related money certain football and basketball players can receive.
